The Global GLP-1 Receptor Agonist Market Size is expected to reach USD 24.2 billion by 2032, at a CAGR of 6.09% during the forecast period 2022 to 2032.GLP-1 receptor agonists bind to and activate GLP-1 receptors to promote physiological processes in the body. GLP-1 receptor agonists enhance insulin secretion by interacting with GLP-1 receptors in pancreatic beta cells. As a result, GLP-1 receptor agonists can be utilized to treat diabetes.

The Global GLP-1 Receptor Agonist Market Size is expected to reach USD 24.2 billion by 2032, at a CAGR of 6.09% during the forecast period 2022 to 2032.GLP-1 receptor agonists bind to and activate GLP-1 receptors to promote physiological processes in the body. GLP-1 receptor agonists enhance insulin secretion by interacting with GLP-1 receptors in pancreatic beta cells.